NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹339 Cr | ₹278 Cr | ₹318 Cr | ₹258 Cr | ₹152 Cr |
What is the latest Revenue of NGL FINECHEM ?
Year | Revenue |
---|---|
Mar2024 | ₹339 Cr |
Mar2023 | ₹278 Cr |
Mar2022 | ₹318 Cr |
Mar2021 | ₹258 Cr |
Mar2020 | ₹152 Cr |
How is Revenue of NGL FINECHEM Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹339 Cr | 21.79 | |
Mar2023 | ₹278 Cr | -12.42 | |
Mar2022 | ₹318 Cr | 23.08 | |
Mar2021 | ₹258 Cr | 70.07 | |
Mar2020 | ₹152 Cr | - |
Compare Revenue of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹682.7 Cr | -0.9% | 1.9% | -51% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,971.0 Cr | -7.3% | 1.1% | 15.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,153.0 Cr | -3.5% | 12.9% | 53.4% | Stock Analytics | |
CIPLA | ₹122,717.0 Cr | 0.1% | 9.2% | 6.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,392.0 Cr | -1% | 0.2% | 19.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,702.0 Cr | 3.1% | 9.8% | -7.6% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -0.9% |
1.9% |
-51% |
SENSEX | 0.6% |
11% |
10.4% |
You may also like the below Video Courses